The Trump administration is exploring the possibility of banning diesel exports to tackle soaring diesel prices, which have reached a record $6.53 per gallon in the U.S. Treasury Secretary Scott Bessent said they are assessing the feasibility of a full or partial ban based on refining capacity. President Trump indicated a swift decision would be made and has expressed support for stopping diesel exports to help lower domestic prices. This move aims to address a 77% price increase compared to last year, reflecting concerns over fuel affordability and supply.
Diesel prices in the U.S. have surged to a record $6.53 per gallon as the Trump administration considers a diesel export ban. For readers following U.S. stock market activity, here is Pluang's market snapshot as of Sep 23, 2026 00:51 WIB: out of 150 priced US stocks tradable on Pluang, 78 rose and 72 fell today. Notable movers include Pinterest Inc (PINS) at USD 18.45 with a 1-day change of -4.65%, Novavax Inc (NVAX) at USD 10.88 with a 1-day change of +4.51%, and Adobe Systems Inc (ADBE) at USD 238.92 with a 1-day change of -4.25%.
Dapirolizumab pegol (DZP), an investigational biologic for systemic lupus erythematosus (SLE), demonstrated greater treatment response rates compared to placebo when combined with standard care in the Phase 3 PHOENYCS GO trial. Using a novel Treatmen...
Valneva announced positive Phase 2 trial results for its tetravalent Shigella vaccine candidate S4V2, showing a favorable safety profile and encouraging immune responses in infants and adults. The infant trial in Kenya demonstrated significant antibo...
argenx will acquire Unnatural Products (UNP) for $550 million upfront plus up to $600 million in milestones, totaling about $1.15 billion. UNP specializes in orally-delivered macrocyclic peptides targeting previously undruggable diseases, enhancing a...
argenx announced it will acquire Unnatural Products, Inc. (UNP) for up to $1.15 billion, including upfront and milestone payments. This acquisition adds UNP's macrocyclic peptide discovery platform to argenx's antibody engineering capabilities, broad...
ClearPoint Neuro reported solid third-quarter results, driven by increased revenue from its drug delivery services and steady sales in neurosurgery navigation equipment. The company sees encouraging signs for future growth in disposables linked to ca...
